Review of Literature: Chapter - 2
Review of Literature: Chapter - 2
Review of Literature: Chapter - 2
REVIEW OF LITERATURE
77
Shinohara and co-workers8 (2008) studied the relationship
between the silalic acid concentration in serum and whole saliva in rats
with naturally occurring gingivitis. They suggested that the amount of
sialic acid in saliva can be a useful index of the severity of periodontal
disease.
78
fluorescence measured in uninfected control cells, indicicsating the
increased accumulation of interacellular ROS in in infected cell lines.
79
glycoprotein-dependent secretion may lead to higher MXF epithelial
lining fluid concentrations than those in plasma. Furthermore, drug- drug
interactions may be expected when MXF is combined with other P-
glycoprotein substrates or modulators.
80
Reddy, Y.N.20 et al (2004) studied the Severe oxidative stress
has been reported in TB patients because of malnutrition and poor
immunity. The purpose of this study was to investigate the serum lipid
peroxidation products and important free radical scavenging enzymes
i.e. superoxide dismutase (SOD), catalase and antioxidant glutathione
levels and total antioxidant status in TB patients. The subjects for this
study comprised of normal human volunteers (NHV,n=25), TB patients
(n=l00) – including, untreated (TB 1, n=55), under treatment (TB2,
n=30) and after treatment (TB3, n = 15) with anti-tuberculosis therapy
(ATT). The levels of lipid peroxidation products malondialdehyde
(MDA) were increased significantly in TB 1 & TB2 (P<0.001) and also
in TB3 (P<0.01); these levels gradually decreased with clinical
improvement with ATT. SOD, catalase, glutathione levels and total
antioxidant status were decreased significantly in TB 1 & TB2
(P<0.00l), TB3 (P<0.0l) patients in comparison with NHV, these levels
gradually increased with clinical improvement with ATT.
Oxidative stress was observed in all the TB patients (TB 1, TB2, TB3),
irrespective of treatment status. The study showed that in TB patients
free radical activity is quite high and antioxidant levels are low. A
suitable antioxidant therapy may prove beneficial and nutritional
antioxidant supplementation may represent a novel approach to fast
recovery.
81
(GSH)). This study was conducted on 25 adult chronic periodontitis
sufferers who were patients in Rajah Muthiah Dental College and
Hospital, Annamalai University. The levels of TBARS and non-
enzymatic antioxidants, and the activities of enzymatic antioxidants in
the patients' plasma, erythrocytes and gingival tissues were assayed
using specific colorimetric methods. The periodontitis sufferers had a
significantly higher TBARS level than the healthy subjects. In the
plasma, erythrocytes, erythrocyte membranes and gingival tissues of
the periodontitis sufferers, enzymatic antioxidant activities were found
to be significantly higher, whereas the levels of non-enzymatic
antioxidants were significantly lower (except for reduced glutathione
in the gingival tissues) relative to the parameters found for healthy
subjects. The disturbance in the endogenous antioxidant defense
system due to over-production of lipid peroxidation products at
inflammatory sites can be related to a higher level of oxidative stress in
patients with periodontitis.
82
results using Duncan multiple range test, pulmonary tuberculosis
infected subjects presented significantly higher mean values of plasma
lipid peroxide (p<0.05) when compared with control. Also the levels of
non-enzymic antioxidants such as Vitamin C, vitamin E and reduced
glutathione in plasma were significantly depleted in the pulmonary
tuberculosis infected subjects (p<0.05) when compared with control.
This shows that pulmonary tuberculosis could probably be associated
with excess ROS production.
83
Reddy, Y. Narsimha24 et al (2009) studied the the pleural fluid
was aspirated from the tuberculous patients both untreatedand under
treatment with three months anti-tuberculosis therapy. The amountof
nalondialdehyde, lactate dehydrogenase, and total protein content in
pleuralfluid of untreated tuberculous patients were found to be
significantly higher when compared with under treatment group. The
pleural fluid total antioxidant levels were significantly lower in
untreated cases in comparison to under treatment. Decrease in the total
antioxidant status was more pronounced in untreated cases, established
that antioxidants were nearly completely utilized to scavenge the free
radicals. Our findings further support the importance of antioxidants in
the treatment of tuberculous patient. This work is licensed under a
Creative Commons Attribution 3.0 License. You are free to copy,
distribute and perform the work. You must attribute the work in the
manner specified by the author or licensor phase of methanol: water
(70: 100) containing 550 mL of H3P04 with 80 nM of NaOH and 20
mL sample was injected. Catalase measurement was done based on the
ability of catalase to oxidize hydrogen peroxide (Beers and Sizer,
1952). The change in absorbance was measured for was measured at
240 nm for 3 min. The results were expressed in terms of IU/mL of
pleural fluid. For the estimation of total antioxidant status, we used a
stable free radical ,-diphenyl--picryl hydrazyl (DPPH), at the
concentration of 0.2 mM in methanol (Blios, 1958; Kalpana et al.,
2001), ascorbic acid was used as a reference standard. The standard
graph was plotted using different concentrations of ascorbic acid and
the antioxidant status values were expressed in terms of nM of ascorbic
acid. Lactate dehydrogenase is zinc containing intracellular enzyme
concerned with reversible oxidation of pyruvate to lactate, involves in
glycolytic cycle. The reaction velocity is determined by a decrease in
84
absorbance at 340 nm resulting from oxidation of NADH (Varley et al.,
1980). Pleural fluid total protein content was estimated by the method
of Lowry et al., 1951. Proteins form chromophoric complex with
phenol reagent, which was measured at 610 nm using UV-VIS
spectrophotometer (Elico, SL- 150). The protein content was calculated
from standard curve prepared with bovine serum albumin and
expressed in terms of g%. Statistical evaluation was done using student
t-test. Lipid peroxidation product and malondialdehyde level estimated
in the pleural fluid of tuberculous patients (Table 1) was significantly
decreased (p<0.001) in under treated cases when compared with
untreated cases. The levels were decreased with clinical improvement
with anti-tuberculosis therapy. The pleural fluid lipid peroxide levels
were found to be significantly high (p<0.001) in untreated cases in
comparison with under treated cases of all three categories used
different treatment regimens, the lipid peroxidation levels were more in
category 2. In the present study catalase level in pleural fluid of the
both untreated and under treated cases it was found that the difference
was not statistically significant and the catalase level was low even
after completion of antituberculosis therapy. The antioxidant levels
were increased significantly (p<0.01) in under treated cases in
comparison with untreated cases. The pleural fluid antioxidant status in
under treatment patients with different treatment regimen, in category
1 and 3 was significantly increased (p<0.01) in comparison with
untreated patients, there was no significant variation in category 2
(Table II). Lactate dehydrogenase level was decreased significantly
(p<0.01) in under treated cases in comparison with untreated cases. In
tuberculous patients based on treatment regimen, the pleural
85
tluidlactate dehydrogenase levels were decreased
Samudram, P.25 et al (2009), investigated the case-control study
followed by a longitudinal cohort study was undertaken to
evaluate the level of lipid peroxidation product malondialdehyde
(MDA) and nitrite as an indirect measurement of nitric oxide vis-à-vis
the levels of antioxidants vitamin C and vitamin E in pulmonary
tuberculosis. Fifty-six sputum smear-positive cases or pulmonary
tuberculosis based on Ziehl-Neelsen (ZN) staining and 50
healthy controls without any systemic disease were included in this study.
Thirty-five cases were longitudinally followed up with standard
antituberculosis chemotherapy (ATT) for two months. Serum levels of
malondiadehyde (MDA), nitrite. and plasma levels of vitamins C and E
were measured. The mean serum MDA level was significantly higher
(8.1 ± 1.61 nmoles/ml) in PTB patients before commencement of ATT
as compared to healthy controls (3.45 ± 1.7 nmoles/ml) (p=0.0001) and
decreased significantly after 2 months of ATT (3.84 ± 1.28 nmoles/rnl)
(p=0.0001). The mean serum nitrite level (47.19 ± 18.44 mol/l) was
significantly elevated before A TT compared to healthy controls (32.89
±11.94 moles/l) and decreased significantly after 2 months of ATT
(27.71 ± 11.97 moles/l) (p=0.0001). The mean plasma levels of
vitamins C (0.88 ± 0.33 mg/dl) and E (0.79 ± 0.24 mg/dl) in PTB
patients before commencement of A TT were lower than healthy
controls (1.42 ± 0.38 mg/dl) and (1.35 ± 0.35 mg/dl), respectively
(p=0.001). There was a significant increase in vitamin C levels after 2
months of ATT (1.19 ± 0.40 mg/dl) compared to before A TT (0.83 ±
0.31 mg/dl) (p=0.0001), but no significant change in mean plasma
vitamin E level before and after 2 months on A TT was found. Elevated
malondialdehyde and nitrite levels with concomitant depressed vitamin
86
C and E levels are indicative of lipid peroxidation and oxidative stress.
The decrease in levels of malondialdehyde and nitrite with subsequent
increase in vitamin C levels after two months of follow-up indicate a
good response to treatment with standard ATT. Hence, the extent of
oxidative stress in PTB can be evaluated by analyzing lipid peroxidation
product, antioxidant and nitric oxide levels.
87
activity might be used as a non specific prognostic marker is assessing
cellular and mitochondrial tissue destruction.
88
effectiveness of catalase when expressed In the mitochondrial
compartment is dependent upon the oxidant and the locus of ROS
production.
89
erythrocytes. Methods: This study has been conducted on 32 adult
female cervical cancer patients and an equal number of age- and sex-
matched normal subjects. Erythrocyte concentrations of lipids,
TBARS, vitamin E, reduced glutathione and enzymic activities of
catalase and Na+K+-ATPase were measured as well as plasma
concentrations of sodium and potassium. The present study also
examined the changes in erythrocyte osmotic fragility in cervical
cancer patients and normal subjects. The red cell fluidity and
permeability were determined by estimating the C/P ratio and Na+K +-
ATPase activity, respectively. Results: The release of thiobarbituric
acid reactive substances was significantly higher in cervical cancer
patients as compared to normal subjects. The increased lipid
peroxidation with concomitant decrease in antioxidants was notable in
cervical cancer patients. Red blood cells of cervical cancer patients
were more fragile than those from normal subjects. Increase in red cell
membrane C/P ratio and Na +K+-ATPase activity was noticed in
cervical cancer patients as compared to normal subjects. Conclusions:
Increased lipid peroxidation, insufficient antioxidant potential and
changes in C/P molar ratio as well as activity of Na +K+-ATPase cause
structural and functional abnormalities in the erythrocytes of cervical
cancer patients.
90
univariate predictors of therisl of catiorasalar events whereas SOD
hasdno association with rick based on the background that cellular
antioxidants enzymes such as GPx 1 and superoxide dismetase have
acentral role in the control of reactive oxygen species and data and
studies in animals models suggest that there enzymes may protect
against arherosclerons but little is known about their releave to
hinadiseas.
91
pulmonary artery pressures (Ppa) were assessed with Doppler
echocardiography.Serum concentrations of MDA and activities of GPX,
SOD and CAT in washed red blood cells were measured using
spectrophotometry. Pulmonary hypertension was present in 28 patients
with COPD (systolic Ppa: 46.4 ± 2.3 mmHg; mean Ppa: 26.0 ± 1.9
mmHg) and absent in 47 (systolic Ppa: 22.9 ± 0.8 mmHg; mean Ppa: 13.4
± 0.6mmHg). Compared with the healthy control group, all the patients
(with or without pulmonary hypertension) had higher serum MDA
concentrations(1.5 ± 0.1 versus 2.3 ± 0.1 versus 2.3 ± 0.1 nmol/mL,
ANOYA, P < 0.001) and lower erythrocyte GPX activity (51.3 ± 3.2
versus 42.2 ± 2.0 versus 41.3 ± 2.5 U/g Hb, P = 0.029), whereas SOD
(1121.1± 29.0 versus 1032.6 ± 21.8 versus 1032.7 ± 36.2 U/g Hb, P =
0.063)and CAT activities (4.9 ± 0.2 versus 4.6 ± 0.1 versuS 4.7 ± 0.2 U/g
Hb; p= 0.454) were similar. No differences were observed in serum
MDA concentrations or activities of GPX, SOD and CAT in erythrocytes
between COPD patients with and without pulmonary hypertension.
92
no differences in plasma selenium levels or GPx activity. GPx levels
measured by Elisa were elevated in severe asthma. These results are
consistent with an adaptive up regulation of GPx to protect against
oxidative stress.
Halil Ciftci, Ayhan verit, Ercan yeni, Murat Saves46 (2008)
found that in the urine of patients with UTI have higher total
antioxidant spacity (TAC) and lower total peroxide and oxidative
stress, index levels, However TAC and plasma Vitamin C
concentration and higher total peroxide and as 1 levels wer obser ed in
UTI. This condition may be a factor which facilitates the development
of the infection on is secondary to UTI.
Naguva Abdallah ismail47 et al (2009) studied the oxidative stress
status in children with glycogen storage disease by determining
activities of GPx SOD and CAT in liver tissue. They concluded that
oxidative stress could play an important role in the pathogenesis of
glycogen torage disease and increased levels of SOD and GPx were
observed in the study.
93
4.38 u/L in healthy control subjects, whereas the mean for the patients
with bronchial cancer was 18.51 ± 7.85. In pulmonary tuberculosis
patients ADA activities were determined both before and after treatment
and significant decrease was observed in ADA activation after treatment
and serum ADA activity is increased in pulmonary tuberculosis patients,
it may be helpful parameter for monitoring therapy.
94
AS 78, 12, 32, 8 respectively in comparison to the cut off value of 53, 76
U/L as found by other studies.
95
U/L. At an ADA level >33 U/L. The sensitivity, specificity, positive
negative predictive values were 100%, 96, 95% and 100 %
respectively.
96
Kuyucu64 et al (1999) conducted a study on serum ADA activity
in childhood pulmonary tuberculosis serum ADA levels were measured
in 20 children diagnosed with pulmonary tuberculosis (group 1) and 150
children (group 2) including 128 with tuberculosis infection and 22
healthy children . In group 1 the mean serum ADA activity was
74.06±18.5 which was significantly higher than that of group 2 (40.36±
12.00). So it was found serum ADA activity was a useful diagnostic tool
in childhood pulmonary tuberculosis.
97
Conde M.B.77 et al. (2002) studied ADA levels in serum for the
diagnosis of tuberculosis and ADA levels have been followed during the
tuberculosis treatment 14 is accepted as cut off value for ADA. Bhargave
et al and al shamary et al accepted the cut off value of serum as a level as
78, 12 and 32, 8.
Verma78 et al (2004) studied the serum ADA activity in serum and
pleural fulid in patiens affected with pulmonary tuberculosis and other
common non tubercular chronic respiratory diseases. The study was
carried out on patients suffering from various pulmonary diseases, the
study revealed that the serum ADA activity was higher in patients of
pulmonary tuberculosis and pleural diseases and non tuberculosis
pulmonary diseases than in control subjects. The mean serum ADA
activity in the patients group was 35.5±6.93l as compared to
16.60±2.85.
K. Pratibha79 et al (2004) reported that patients with liver
disease showed significantly higher levels of serum bilirubin and
enzymes as compared with control group , a comparison between
patients and controls for ADA ,5'NT and MDA,all three parameters were
found to be significantly higher in patient group
Sharma, S.K80 . et al (2006) evaluated that diagnostic accuracy
and cost-effectiveness of ascitic fluid interferon- (IFN-) and
adenosine deaminase (ADA) assays in the diagnosis of tuberculous
ascites. Ascitic fluid from patients with proven tuberculosis (TB) (n =
31) and non-TB ascites (n = 88) was analyzed for IFN- and ADA
levels. Areas under the receiver operative characteristic (ROC) curves
(AUCs) for the two biologic markers were compared. Levels of ascitic
fluid IFN-, median (range): 560 (104-1600) pg/mL vs. 4.85 (0–320)
pg/mL (p < 0.001), and ADA, median (range): 58 (16-331) IU/L vs. 10
98
(0-59) IU/L (p = 0.001), were significantly different between TB and
non-TB groups. IFN- and ADA assays showed equal sensitivity (0.97)
and differed marginally in specificity (0.97 vs. 0.94). Difference in
AUCs was not significant (0.99 vs. 0.98, p < 0.62). For differentiating
TB from non- TB ascites, optimal cutoff points were 112 pg/mL for
IFN- and 37 IU/L for ADA. The accuracy of the ADA assay was similar
to that of the IFN- assay in differentiating of TB from non-TB ascites.
Because both material and human costs of the ADA assay are
far less than those of the IFN- assay, the former is probably the most
appropriate diagnostic test for analysis of peritoneal fluid in resource
limited settings.
99
levels were similar in Hand S sensitive group and resistant group
P>0.05). Serum ADA levels were higher in category I group when
compared with the levels of the healthy group (p: 0.03). Comparison
between the serum ADA levels of the groups of category I, II and IV
with each other showed that the values of category I were significantly
higher than values of category II (p=0,038). Although there were no
statistically significant differences, it was shown that when the number
of resistant drugs increased, the mean serum ADA level tend to
decrease. In conclusion, serum ADA levels of category I patients were
higher than healthy group and while the number of resistant drugs
increasing, ADA levels were decreasing.
100
immediate diagnosis of TB pleuritis while waiting for culture result and
this has a positive impact on patients routine.
101
formation in response to oxidative stress can be influence by changes
in the poly unsaturated fatty acid composition of cell lipid and suggest the
possibility that carbon centered lipid radicals may interact with
extracellular structure.
102
depletion of these cells is associated with increased susceptibility to TB
in both animals and humans.
103
arachnoid space. High CSF nitrotyrosine concentration were associated
with an unfavorable outcome according to the Glasgow outcome score
in CSF the increase in nitrotyrosine was accompanied by a depletion of
the antioxidant ascorbic acid and an increased oxidation of natural
peroxinitrite scavenger uric acid to allantoin.
104
Ceylan105 et al (2005) found that in TB patients the levels of
serum reactive oxygen metabolites were increased as compared to
normal controls ,therefore building up oxidative stress in the patients.
105
meningitis, honey, cardovas cular disease, poli unsaturated fat,
defence mechanism, mico bacterium, lung injury, but hardly any
study is traced as is under consideration.
Researches in the area of antioxidants have been conducted on
leprosy, mental disorders, several falinic , hapetic apurecrosis,
immunology, asthma, but not even few researches are found
related to pulmonary tuberculosis with the combination of
parameters as considered in this study.
Studies on glycoprotein have been reported on levels of
glycoprotein, glycoprotein pattern, immuno compromised. Very
few studies have been observed that too with the variation from
this study.
Vitamin E has been studied in case of inflammatory disease IDB
patients micronutrients, T cells, reactive oxygen species and
vitamin E selenium etc. Hence the studies on vitamin E and
sputum +ve and sputum -ve pulmonary tuberculosis are very few to
report.
106
REFERENCES
1. Morishita K, Komiya Y, Matsubayashi H. (1965) Progress of
medical parasitology in Japan Volume II. Tokyo, Japan: Meguro
parasitological museum; 1965. pp. 88-167.
2. O. P. Mital, T. N. Singh, S. K. Singh, M. C. Agrawal, and B. K.
Sur (1966) Study of Serum Glycoproteins in Pulmonary
Tuberculosis CHEST October 1966 vol. 50 no. 4 372-379.
3. William P. Bradley MS, Andrew P. Blasco MS, Joseph F. Weiss
PhD, John C. Alexander Jr. MD, Norman A. Silverman MD,
Paul B. Chretien MD. (1977) Correlations among serum protein-
bound carbohydrates, serum glycoproteins, lymphocyte reactivity,
and tumor burden in cancer patients. Cancer Volume 40, Issue 5,
pages 2264-2272, November 1977.
4. Leif C. Andersson, Kimmo K. Karhi, Carl G. Gahmberg, Hans
Rodt (1980) Molecular identification of T cell-specific antigens
on human T lymphocytes and thymocytes European Journal of
Immunology Volume 10, Issue 5, pages 359-362, May 1980.
5. N. Stefenelli, H. Klotz, A. Engel and P. Bauer (1985) Serum
sialic acid in malignant tumors, bacterial infections, and chronic
liver diseases Journal of Cancer Research and Clinical Oncology
1985 Volume 109, Number 1, 55-59.
6. Singh U, Solanki RL, Anand VK, Ramdeo IN. (1989) Serum
glycoproteins in pulmonary tuberculosis. Indian J Med Res. 1989
Jul;89:255-60.
7. Fassbender K, Mobner R, Motsch L, Kischka U, Grau A,
Hennerici M. Circulating selectin- and immunoglobulin-type
adhesion molecules In acute ischemic stroke. Stroke.
1995;26: 1361-1364.
107
8. Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H. (2008)
Alternative translation of osteopontin generates intracellular and
secreted iso forms that mediate distinct biological activities in
dendritic cells. Proc Natl Acad Sci USA; 105 :723 5-7239.
9. Kalyan Goswami, Dalavaikodihalli Nanjaiah Nandakumar,
Bidhan Chandra Koner, Zachariah Bobby and Sanat Kumar Sen
(2003) Oxidative changes and desialylation of serum proteins in
hyperthyroidism Clinica Chimica Acta Volume 337, Issues 1-2,
November 2003, Pages 163-168.
10. Albillos A, de-la-Hera A, Alvarez-Mon M. (2004) Serum
lipopolysaccharide-binding protein prediction of severe bacterial
infection in cirrhotic patients with ascites. Lancet. 2004 May 15;
363 (9421):1608-10.
11. Kasahara Y, Kazuyuki I, Yachie A, et al. (2004) Involvement
of reactive oxygen intermediates in spontaneous and CD95
(Fas/APO-l)- mediated apoptosis of neutrophils. Blood 1997;
89: 1748- 1753.
12. Song-Ze Ding, Yutaka Minohara, Xue Jun Fan,Jide Wang,
Victor E. Reyes, Janak Patel, Bernadette Dirden-Kramer, Istvan
Boldogh, Peter B. Ernst, and Sheila E. Crowe; Helicobacter
pylori Infection Induces Oxidative Stress and Programmed Cell
Death in Human Gastric Epithelial Cells , Infection and
Immunity, August 2007, p. 4030-4039, Vol. 75, No.8.
13. H M Erdogan, M Karapehlivan, M Citil, 0 Atakisi, E Uzlu, A
Unver (2008) Serum sialic acid and oxidative stress parameters
changes in cattle with leptospirosis Veterinary research
communications. 01/04/2008; 32(4):333-9.
108
14. Julien Brillault, Whocely Victor De Castro, Thomas Harnois,
Alain Kitzis, Jean-Christophe Olivier, and William Couet (2009)
P-Glycoprotein-Mediated Transport of Moxifloxacin in a Calu-3
Lung Epithelial Cell Model, Antimicrobial Agents and
Chemotherapy,, p. 1457-1462, Vol. 53, No.4.
15. Fernandez-Banares F; Abad-Lacruz A; Xiol X; Gine J J; Dolz
C; Cabre E; Esteve M; Gonzalez-Huix F.; Gassull M. A. (1989)
Vitamin status in patients with inflammatory bowel disease. The
American journal of gastroenterology 1989; 84 (7):744-8.
16. Kuroki F, Iida M, Matsumoto T, et al. 1997 Serum n3
polyunsaturated fatty acids are depleted in Crohn's disease. Dig
Dis Sci,; 42:1137-1141.
17. Plit ML, Theron AJ, FickI H, Van Rensburg CE, Pendel S,
Anderson R. (1998) Influence of antimicrobial chemotherapy
and smoking status on the plasma concentrations of vitamin C,
vitamin E, beta carotene, acute phase reactants, iron and lipid
peroxides in patients with pulmonary tuberculosis. Int J Tuberc
Lung Dis. 1998; 2: 590-96.
18. B. 1. Geerling (1999) The Relation between Antioxidant Status
and Alterations in Fatty Acid Profile in Patients with Crohn
Disease and Controls 1999, Vol. 34, No. 11, Pages 1108-1116.
19. Lettow van M, Fawzi WW & Semba RD. (2003) Triple trouble:
the role of malnutrition In tuberculosis and human
immunodeficiency virus co-infection. Nutr. Rev. 61: 81-90.
20. Reddy YN, Murthy SV, Krishna DR, Prabhakar MC. (2004)
Role of free radicals and antioxidants in tuberculosis patients.
Indian J Tuberc. 2004; 51: 213-18.
109
21. Panjamurthy, K., Manoharan, S., Ramachandran, C. R. (2005).
Lipid peroxidation and antioxidant status in patients with
periodontitis, Cell. Mol. BioI. Lett 10, 255-64.
22. Nwanjo, H.U. and G.O. Oze, (2007). Oxidative imbalance and
non-enzymic antioxidant status in pulmonary tuberculosis infected
subjects: Carcinogenic potential. Pak. J. Nutr., 6 590-592. BMC
Infect Dis. 2004 Dec 21 ;4(1 ):61.
23. Ensiyeh seyedrezazadeh, Alireza ostadrahimi, soltanali
mahboob, Yagoob assadi, jamal ghaemmagami, Masood
pourmogaddam, 2008. Effect of vitamin E and selenium
supplementation on oxidative stress status in pulmonary
tuberculosis patients, Respirology Volume 13, Issue 2, pages
294-298,
24. Y. Narsimha Reddy, S. Vasudeva Murthy, D.R. Krishna and
M.C. Prabhakar (2009) Oxidative metabolic changes in pleural
fluid of tuberculosis Patients, Bangladesh J Pharmacol; 4: 69-72.
25. Samudram, P., Vasuki, R., Rajeshwari, H., Geetha, A. &
Moorthi, P. (2009). Antioxidant and antihepatotoxic activities of
ethanolic crude extract of Melia azedarach and Piper longum.
Journal of Medicinal Plants and Research, 3(12),1078-1083.
26. Safarian MD, Karagezian KG, Karapetian ET, Avanesian NA.
(1990) The efficacy of antioxidant therapy in patients with
tuberculosis of the lung and the correction of lipid peroxidation
processes. Probl Tuberk; 5 : 40-44.
27. ThomasCE, McLean LR, Parker RA, Ohlweiler DF.1992.
Ascorbate and phenolic antioxidant interactions in prevention of
liposomal oxidation. Lipids27: 543-550.
110
28. Jackson P., Loughrey CM., Lightbody JH., McNamee PT.,
Young IS. (1995) Effect of haemodialysis on total antioxidant
capacity and serum antioxidants in patients with chronic renal
failure.Clin.chern. 41 (8 pt 1) 1135-8. (s)
29. Lih-Brody L, Powell SR, Collier KP, Reddy OM, Cerchia
R, Kahn E, Weissman OS, Katz S, Floyd RA, McKinley
MJ, Fisher SE, Mullin OE. (1996) Increased oxidative stress and
decreased antioxidant defenses in mucosa of inflammatory bowel
disease. Dig Dis Sci. 1996 Oct;41 (10):2078-86.
30. Durak H, Canbolat 0, Kavutcu M, Ozturk HS; Yurtarslani Z.
(1996) Activities of total, cytoplasmic and mitochondrial
superoxide dismutase enzymes in sera and pleural fluids from
patients with lung cancer. J Clin Lab Anal 1996; 10: 17-20.
31. Rock CL, Jacob RA, Bowen PE. (1996) Update on the
biological characteristics of the antioxidant micronutrients:
Vitamin C, vitamin E and carotenoids. J Am Diet Assoc. 1996;
96: 693- 704.
32. B. J. Geerling (1999). The Relation between Antioxidant Status
and Alterations in Fatty Acid Profile in Patients with Crohn
Disease and Controls 1999, Vol. 34, No. 11 , Pages 1108-1116.
33. Chan C, Goldkorn T. (2000) Ceramide path in human lung cell
death. Am J Respir Cell Mol BioI. 2000; 22: 460-68.
34. Gouaze V, Mirault ME, Carpentier S, Salvayre R, Levade T,
Andrieu-Abadie N (2001) Glutathione peroxidase-l
overexpression prevents ceramide production and partially
inhibits apoptosis 10 doxorubicin-treated human breast carcinoma
cells. Mol Pharmacol 60: 488-496.
111
35. Jingxiang Bai, Arthur 1. (2001) Cederbaum Mitochondrial
Catalase and Oxidative Injury Bioi Signals Recept 2001; 10: 189-
199.
36. Jose M. Mates, J. Carlos Aledo, Cristina Perez-Gomez, Alicia
Esteban del Valle, Jose M. Segura (2002) Interrelationship
between oxidative damage and antioxidant enzyme activities: an
easy and rapid experimental approach Biochemical Education
Volume 28, Issue 2, pages 93-95, March 2.
37. Nobuya Ishibashi, Olga Prokopenko, Kenneth R. Reuhl and Oleg
Mirochnitchenko (2002) Inflammatory Response and
Glutathione Peroxidase in a Model of Stroke' The Journal of
Immunology, 2002,168: 1926-1933.
38. Kolanjiappan, K., Manoharan, S. and Kayalvizhi, M. (2002).
Measurement of erythrocyte lipids, lipidperoxidation,
antioxidants and osmotic fragility in cervical cancer patients.
Clin. Chin. Acta. 326,143-149.
39. Reddy Y N; Murthy S V; Krishna D R; Prabhakar M C (2003)
Oxidative stress and anti-oxidant status in leprosy patients.
Indian journal of leprosy; 75(4):307-16.
40. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner
G, Tiret L, Smieja M, Cambien F, Meyer J, Lackner KJ; (2003)
AtheroGene Investigators. Glutathione peroxidase 1 activity and
cardiovascular events in patients with coronary artery disease. N
Engl J Med. 23; 349(17): 1605-13.
41. Crapo JD (2003). Oxidative stress as an initiator of cytokine
release and cell damage. Eur Respir J Suppl; 44: 4s-6s.
42. Joppa, P, Petrasova, D, Stancak, B, et al (2006) Systemic
inflammation in patients with COPD and pulmonary
112
hypertension. Chest 130,326-333.
113
a diagnostic test. Tubercle 1987; 68: 137-40 Fontan Bueso J,
Verea Hernand.
50. Segura RM, Pasqual C, Ocana I et al. (1989) Adenosine
deaminase in body fluids a useful diagnostic tool in tuberculosis.
Clin Biochem 1989; 22: 141-8.
51. Gupta DK, Suri JC, Goel A. (1990), Efficacy of ADA in
diagnosis of pleural effusions. 1nd J Chest Dis 1990; 32 (4):
205-208.
52. Jeronimo Jaqueti et al. (1990) Adenosine Deaminase in
Pregnancy Serum. Clin.Chem. 1990; Vol 3 6, No 12, 2144.
53. Ida T, S Taniai, M Nitta, J Shimase, K Makiguchi, I Miyasato, et
al. (1990) Serum adenosine deaminase activity in patients with
active pulmonary tuberculosis. Kekkaku. 1990;65:477-81.
54. Bhargava DK, M Gupta, S Nijhawan, S Dasarathy, AK
Kushwaha. (1990) Adenosine deaminase (ADA) in peritoneal
tuberculosis: Diagnostic value in ascitic fluid and serum.
Tubercle. 1990;71:121-6.
55. Agarwal MK, Jitendra Nath, Mukerji PK, V.M.LSrivastava.
(1991) A study of serum Adenosine Deaminase activity in
Sputum Negtive patients of Pulmonary Tuberculosis. Ind J.Tub.
1991; 38: 139-141.
56. Meftun U., Ayse Berna D., Berna 6., Nurhan S., Mihriban O.,
Turkan E. (1995) The role of serum adenosine deaminase levels
in determination of disease activity of patients with pulmonary
tuberculosis Turk J Med Res 1995; 13 (6)
57. Lakshmi V, Rao RR, Joshi N, Rao PN (1992). Serum adenosine
deaminase activity in bacillary or paucibacillary tuberculosis.
Indian J Pathol Microbiol 1992; 35: 48-52.
114
58. Burgess L.J. (1995) Use of adenosine deaminase as a
diagnostic tool for tuberculous pleurisy. Thorax 1995 June; 50
(6): 672-674.
59. Kelbel C, Stumpf B, Schmidt W, et al (1995). Die rolle der
serum-adenosindeaminase als immunparameter der tuberkulose.
Pneumologie 1995; 49:684-88.
60. Rohani MY, Cheong YM, Rani JM. (1995) The use of
adenosine deaminase activity as a biochemical marker for the
diagnosis of tuberculous meningitis. Malays J Pathol. 1995
Dee; 17(2):67-71.
61. Ferrer J. (1997) Pleural tuberculosis. Eur Respir J 1997; 10:942-7.
62. Paliwal R, Shah K.V. (1998) Serum adenosine deaminase es-
timation in patients with Pulmonary Tuberculosis and other non
tuberculosis respiratory conditions. Indian J of Tuberculosis.
1998; 45(3): 174.
63. Collazos J, Espana P, Mayo J, Martinez E, Izquierdo F (1998)
Sequential evaluation of serum adenosine deaminase in patients
treated for tuberculosis. Chest. 1998; 114:432-5.
64. Kuyucu K, C Karakurt, E Bialaloglu, T Karacan, T Tezic. 1999)
Adenosine deaminase in childhood pulmonary tuberculosis:
diagnostic value in serum. 1. Trop. Paediatr. 1999;45:245-7.
65. Raintawan,p et al (1999).Diagnostic value of pleural fluid
adenosine deaminase in tuberculous pleuritis with refrence to
HIV co-infection and a Bayesian analysis .Chest, 116:97-103.
66. Valdes,L et aI, (1996). Adenosine deaminase isoenzyme analysis
in pleural effusions: diagnostic role and prevelance to the origin
of increased ADA in tuberculous pleurisy.EuLRespirJ.,9:797-
751.
115
67. Burgess L.J. (1995) Use of adenosine deaminase as a diagnostic
tool for tuberculous pleurisy. Thorax 1995 June; 50 (6): 672-674.
68. Aggarwal, A.N., ET AL (1999).Diagnosis of tuberculous pleural
effusion. Indian. J .Chest .Dis.AlIied Sci.,41: 89-100.
69. Roth, BJ., (1999).Searching for tuberculosis in pleural
space. Chest, 116:3-5.
70. Collazos J et al (1998) .Sequential evaluation of serum
adenosine deaminase in patients treated for tuberculosis.
Clin.Invest, 114:432-435.
71. Bansal, S.K et al.,(1991 ).Serum Adenosine deaminase in
pulmonary tuberculosis ;malignancy and non tubercular
respiratory tuberculosis .Indian .J.Chest.Dis.AlIied Sci.,33: 189-
193.
72. Segura et al (1989).Adenosine deaminase in body fluids :a useful
diagnostic tool in tuberculosis.clin. biochem, 22:141-148.
73. Conde MB, SR Marinho, F Pereira-Mde, JR Lapae-Silva, MH
Saad, CL Sales, et al. (2002) The usefulness of serum
adenosine deaminase 2 (ADA-2) activities in adults for the
diagnosis of pulmonary tuberculosis. Respir. Med. 2002; 96:607-
10. J.Med. Sci. 2003; 3:30-45.
74. Mishra OP, Yusaf S, Ali Z, Nath G, Das BK. (2000) Adenosine
deaminase activity and lysozyme levels in children with
tuberculosis. J Trop Pediatr 2000; 46: 175-8.
75. Yash P. Kataria, Imtiaz Khurshid, (2001) Adenosine Deaminase
in the Diagnosis of Tuberculous Pleural Effusion CHEST August
2001 vol. 120 no. 2 334-336.
76. Dilmac A, Ucoluk G, Ugurman F et al. (2002), The diagnostic
value of adenosine deaminase activity sputum in pulmonary
116
tuberculosis. RespirMed 2002; 96: 632-4.
117
estimation and multiplex polymerase chain reaction in diagnosis
of extra-pulmonary tuberculosis The International Journal of
Tuberculosis and Lung Disease, Volume 12, Number 10.
84. Kamaldeen Baba, Anwar A. Hoosen, Nina Langeland, Anne M.
Dyrhol-Riise (2008) Adenosine Deaminase Activity Is a
Sensitive Marker for the Diagnosis of Tuberculous Pleuritis in
Patients with Very Low CD4 Counts PLoS One, 2008
85. Leibowitz S, Kennedy L, Lessof MH. (1973) The tuberculin
reaction in the pleural cavity and its suppression by
antilymphocyte serum. Br J Exp Pathol 1973 ;54: 152-62.
86. Mead JF. (1976) Free radical mechanisms of lipid damage and
conseqtiences for cellular membranes. In: Pyror WA, ed. Free
radicals in biology, vol. I. New York: Academic Press, 51-6.
87. May ME, Spagnuolo PJ. (1987) Evidence for activation of a
respiratory burst in the interaction of human neutrophils with
Mycobacterium tuberculosis. Infect Immun. 1987; 55: 2304-07.
88. Halliwell B. (1991) Reactive oxygen species in living systems:
Source, biochemistry and role in human disease. Am J Med
1991; 91: 14-21.
89. D J Silverman, L A Santucci, and P L Gutierrez, Rickettsia
rickettsii (1992) induces superoxide radical and superoxide
dismutase in human endothelial cells. Infect Immun. 1992
December; 60(12): 5113-5118.
90. J. A. North, A. A. Spector, and G. R. Buettner (1994) Cell fatty
acid composition affects free radical formation during lipid
peroxidationAm J Physiol Cell Physiol July 1, 1994 267:C 177-
C188
118
91. Jack CI, Jackson MJ, Hind CR. (1994) Circulating markers of
free radical activity in patients with pulmonary tuberculosis.
Tuber Lung Dis 1994; 75 : 132-137
92. Grimble RF. (1994) Malnutrition and the immune response.
Impact of nutrients on cytokine biology in infection. Trans R Soc
Trop Med Hyg 1994; 88 : 615-619.
93. Raviglione MC, Snider DE, Kochi A. (1995) Global
epidemiology of tuberculosis: morbidity and mortality of a
worldwide epidemic. J Am Med Assoc 1995; 273: 220-6.
94. Sen CK, Packer L. (1996) Antioxidant and redox regulation of
gene transcription. FASEB J. 1996; 10: 709-20.
95. Christopher K. W. Lai, Sheng Ho, Christopher H. S. Chan,
Joseph Chan, Dominic Choy, Roland Leung and Kar-neng Lai
(1997) Cytokine Gene Expression Profile of Circulating CD4 +
T Cells in Active Pulmonary Tuberculosis Chest 1997; 111;606-
611.
96. Subrahmanyam M. (1998) A prospective randomised clinical and
histological study of superficial burn wound healing with honey
and silver sulfadiazine. Burns 1998;24: 157-16l.
97. Kwiatkowska S, Piasecka G, Zieba M, Piotrowski W, Nowak D.
(1999) Increased serum concentrations of conjugated dienes
and malondialdehyde in patients with pulmonary tuberculosis.
Respir Med 1999; 93(4) : 272-276.
98. Bhattacharyya J, Datta AG. (2001) Studies on the effects of
lipopolysaccharide on lipid peroxidation of erythrocyte and its
reversal by mannitol and glycerol. J Physiol Pharmacol. 2001
Mar;52(1): 145-52.
119
99. Makinskii AI, Baikeev RF, Zalialiev RA(2002) : Markers of
alteration of tissue structures as indicators of pulmonary
tuberculosis activity (in Russian). Probl Tuberk 2002;(7):39-42.
100. Kastenbauer S, Koedel U, Becker BF, Pfister HW (2002) :
Oxidative stress in bacterial meningitis in humans. Neurology.
2002 Jan 22;58(2):186-91.
101. Peter Barany Pecoits-Filho Roberto; Heimbtirger Olof; Suliman
Mohamed; Fehrman-Ekholm Ingela; Lindholm Bengt;
Stenvinkel Peter (2003) Associations between circulating
inflammatory markers and residual renal function in CRF
patients. American journal of kidney diseases : the official
journal of the National Kidney Foundation 2003;41(6):1212-8.
102. Figen Deveci and Nevin Ilhan (2003) Plasma malondialdehyde
and serum trace element concentrations in patients with active
pulmonary tuberculosis Biological Trace Element Research
Volume 95, Number 1, 29-38,
103. Guney Yildiz; Bukan Neslihan; Dizman Aysen; Hicsonmez
Ayse; Bilgihan Ayse (2004) Effects of two different high doses
of irradiation on antioxidant system in the liver of guinea pigs.
Eksperimental'nai?a onkologii?a 2004;26(1 ):71-4.
104. Kiranjit Kaur, MD, Jai Kishan, MD, Gurdeep K. Bedi, MD and
Rajinderjit S. Ahi, (2005) OXIDANTS STRESS AND
ANTIOXIDANTS IN PULMONARY TUBERCULOSIS
American College of Chest Physicians. Chest 2005.
105. Erkan Ceylan, Abdullah Gtilstin, Mehmet Gencer, Nurten Aksoy.
(2005) A New Parameter in the Detection of Tuberculosis
Activity: Reactive Oxygen Metabolites Respiration 2005;
72: 156-159.
120
106. Scott W. Walsh (2006) What Causes Endothelial Cell Activation
in Preeclamptic Women American Journal of Pathology.
169:1104-1106.
107. Silvia Carraro and Eugenio Baraldi (2008) Exhaled breath
condensate in children: present knowledge and future prospects
J. Breath Res. 2 Number 3.
121